3//SEC Filing
ARCH Venture Partners IX, L.P. 3
Accession 0001209191-19-052979
CIK 0001706431other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 7:24 PM ET
Size
23.1 KB
Accession
0001209191-19-052979
Insider Transaction Report
Form 3
ARCH Venture Partners IX, L.P.
10% Owner
Holdings
- (indirect: See footnote)
Series B Convertible Preferred Stock
→ Common Stock (555,555 underlying) - (indirect: See footnote)
Series A-1 Convertible Preferred Stock
→ Common Stock (11,111,110 underlying) - (indirect: See footnote)
Series A-1 Convertible Preferred Stock
→ Common Stock (13,333,332 underlying) - (indirect: See footnote)
Series B Convertible Preferred Stock
→ Common Stock (2,222,222 underlying) - 444,444(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]These shares are directly held by ARCH Venture Fund IX, L.P. ("ARCH IX"). ARCH Venture Partners IX, L.P. ("GPLP"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell, Clinton Bybee and Robert Nelsen (the "ARCH Managing Directors"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
- [F2]Each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") is convertible into 1 share of Common Stock. The Preferred Stock has no expiration date.
- [F3]These shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001723173
Filing Metadata
- Form type
- 3
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 7:24 PM ET
- Size
- 23.1 KB